Icahn School of Medicine at Mount Sinai, Genentech
belmont, California, United States
Disclosure information not submitted.
NK-mediated Protection Against Tumor Recurrence in CMV+ Bladder Cancer Patients Upon BCG Treatment
Wednesday, June 19, 2024
4:30 PM – 4:45 PM PT
